View up-to-date information on Agios Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| UA126292C2 | Grant | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | A61K31/5025; A61K31/506; A61K31/519; A61K45/06; A61P3/10; A61P35/00; A61P7/06; A61P7/08; C07D241/36; C07D513/14 | September 14, 2022 |
| IL272599B | Grant | Pyruvate kinase modulators and use thereof | A61K31/5025; A61K31/506; A61K31/519; A61K45/06; A61P3/10; A61P35/00; A61P7/06; A61P7/08; C07D241/36; C07D513/14 | August 01, 2022 |
| US20220233541A1 | Application | PYRUVATE KINASE MODULATORS AND USE THEREOF | A61K31/5025; A61K31/506; A61K31/519; A61K45/06; C07D241/36; C07D513/14 | July 28, 2022 |
| CA2942072C | Grant | PHARMACEUTICAL COMPOSITIONS AND USE OF (S)-1-(2-CHLOROPHENYL)-2-((3,3-DIFLUOROCYCLOBUTYL)AMINO)-2-OXOETHYL)-1-( 4-CYANOPYRIDIN-2-YL)-N-( 5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE | A61K31/444; A61K47/38; A61K9/10; A61K9/146; A61K9/2054; A61P35/00; A61P35/02; A61P43/00; C07B2200/13; C07D251/18; C07D401/14 | July 26, 2022 |
| MY191825A | Grant | THERAPEUTIC COMPOUNDS AND COMPOSITIONS | A61K31/497; A61K31/5513; A61P35/00; A61P9/00; A61P9/10; C07D215/36; C07D215/40; C07D239/42; C07D241/20; C07D241/22; C07D243/08; C07D271/12; C07D277/64; C07D277/68; C07D295/192; C07D319/18; C07D401/12; C07D401/14; C07D403/12; C07D405/12; C07D407/12; C07D409/12; C07D417/12; C07D417/14; Y02P20/582 | July 18, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer